SCHEMBL19081530

SCHEMBL19081530

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6oc7c(ccc8c9ccc%10ccccc%10c9oc87)c6c5)cc4)c4ccccc34)cccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
CYP1A1 P04798 11/20 0.37
CYP1B1 Q16678 11/20 0.37
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 3/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP1A2 P05177 11/20 0.36
CYP2C19 P33261 3/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP3A4 P08684 2/20 0.36
TSHR P16473 2/20 0.36
PRKDC P78527 2/20 0.36
PDE5A O76074 1/20 0.36
TP53 P04637 1/20 0.36
ABCB1 P08183 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16067569 0.97 ALOX5 (0.39) ALOX5CYP1A1CYP1B1ALDH1A1HSD17B10
SCHEMBL19081551 0.94 PLA2G2A (0.38) ALOX5CYP1A1CYP1B1ALDH1A1HSD17B10
SCHEMBL19081527 0.94 ALOX5 (0.37) ALOX5CYP1A1CYP1B1ALDH1A1HSD17B10
SCHEMBL19081526 0.93 ALOX5 (0.36) ALOX5CYP1A1CYP1B1ALDH1A1HSD17B10
SCHEMBL22063399 0.93 ALOX5 (0.38) ALOX5CYP1A1CYP1B1ALDH1A1HSD17B10
SCHEMBL19108717 0.93 ALOX5 (0.45) ALOX5ALDH1A1HSD17B10MAPTHPGD
SCHEMBL10122407 0.93 ALOX5 (0.45) ALOX5ALDH1A1HSD17B10MAPTHPGD
SCHEMBL16068020 0.92 ALOX5 (0.41) ALOX5CYP1A1CYP1B1ALDH1A1HSD17B10
SCHEMBL17945168 0.91 CYP1A1 (0.43) ALOX5CYP1A1CYP1B1ALDH1A1HSD17B10
SCHEMBL16067815 0.91 CYP1A1 (0.39) ALOX5CYP1A1CYP1B1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885CYP1A1 184/4885CYP1B1 260/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885CYP1A1 184/4885CYP1B1 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.